Graduate Student, MD PhD CandidateDivision of Surgical Oncology, Department of Surgery, Department of Microbiology and Immunology, Winship Cancer Institute, Emory University, Atlanta, GA, United States
54: Galectin-9 is a regulator of immune interactions in the tumor microenvironment and represents a novel therapeutic target in biliary tract cancer.
Saturday, March 23, 20248:42am – 8:52am ET
